| Targeting β-catenin overcomes MEK inhibition resistance in colon cancer with KRAS and PIK3CA mutations JH Moon, SW Hong, JE Kim, JS Shin, JS Kim, SA Jung, SH Ha, S Lee, ... British Journal of Cancer 120 (9), 941-951, 2019 | 17 | 2019 |
| Inhibition of JAK1/2 can overcome EGFR-TKI resistance in human NSCLC DM Kim, MJ Kim, JH Moon, EY Lee, JK Hong, S Lee, DI Koh, YS Ryu, ... Biochemical and biophysical research communications 527 (1), 305-310, 2020 | 9 | 2020 |
| CJ14939, a novel JAK inhibitor, increases oxaliplatin-induced cell death through JAK/STAT pathway in colorectal cancer JK Hong, KIM DO YEON, J Shin, YS Ryu, J Moon, DI Koh, S Lee, J Lee, ... Anticancer Research 42 (4), 1813-1819, 2022 | 7 | 2022 |
| Role of p53 in transcriptional repression of SVCT2 EH Kim, DI Koh, YS Ryu, SS Park, SW Hong, JH Moon, JS Shin, MJ Kim, ... Molecular Biology Reports 48, 1651-1658, 2021 | 4 | 2021 |
| Chemosensitivity to HM90822, a novel synthetic IAP antagonist, is determined by p-AKT-inducible XIAP phosphorylation in human pancreatic cancer cells SW Hong, JS Shin, JH Moon, SA Jung, DI Koh, Y Ryu, YS Park, DY Kim, ... Investigational New Drugs 38, 1696-1706, 2020 | 4 | 2020 |
| Mutation SVCT2 promotes cell proliferation, invasion and migration in colorectal cancer SS Park, YS Ryu, DI Koh, SW Hong, JH Moon, JS Shin, MJ Kim, JK Hong, ... Journal of Cancer 12 (18), 5385, 2021 | 2 | 2021 |
